
The Evolution of Risk Assessment in Pulmonary Arterial Hypertension
Author(s) -
Sandhya Murthy,
Raymond L. Benza
Publication year - 2021
Publication title -
methodist debakey cardiovascular journal
Language(s) - English
Resource type - Journals
eISSN - 1947-6094
pISSN - 1947-6108
DOI - 10.14797/lrpr7655
Subject(s) - medicine , intensive care medicine , lung transplantation , referral , risk assessment , pulmonary hypertension , disease , transplantation , cardiology , family medicine , computer security , computer science
Pulmonary arterial hypertension (PAH) is a chronic debilitating disease that carries an unacceptably high morbidity and mortality rate despite improved survival with modern therapies. The combination of several modifiable and nonmodifiable variables yields a robust risk assessment across various available clinical calculators. The role of risk calculation is integral to managing PAH and aids in the timely referral to expert centers and potentially lung transplantation. Studies are ongoing to determine the role of risk calculators in the framework of clinical trials and to elucidate novel markers of high risk in PAH.